Latamoxef
| Code | Size | Price |
|---|
| TAR-T21413-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Latamoxef is an oxacephem antibiotic and is a member of the cephalosporins.
CAS:
64952-97-2
Formula:
C20H20N6O9S
Molecular Weight:
520.47
Purity:
0.98
SMILES:
[H][C@]12OCC(CSc3nnnn3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)c1ccc(O)cc1)OC)C(O)=O
References
1. Hagiya H, Tasaka K, Sendo T, Otsuka F. Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection. Infect Drug Resist. 2015 Oct 20;8:353-7. doi: 10.2147/IDR.S90726. eCollection 2015. PubMed PMID: 26527890; PubMed Central PMCID: PMC4621224.
2. Ito A, Tatsumi Y, Wajima T, Nakamura R, Tsuji M. Potent antibacterial activities of latamoxef (moxalactam) against ESBL producing Enterobacteriaceae analyzed by Monte Carlo simulation. Jpn J Antibiot. 2014 Apr;67(2):109-22. PubMed PMID: 24956910.
3. Gu HY, Sun DM, Yu AM, Chen HY. [Polarographic behavior of latamoxef sodium and its trace determination]. Yao Xue Xue Bao. 1997 May;32(5):373-6. Chinese. PubMed PMID: 11498875.
4. Chen YC, Hung CC, Lin SF, Chang SC, Hsieh WC. Comparison of flomoxef with latamoxef in the treatment of sepsis and/or Gram-negative bacteremia in adult patients. Int J Antimicrob Agents. 1996 May;7(1):69-74. PubMed PMID: 18611739.